Allogeneic Bone Marrow Transplantation in a Patient with Chemotherapy-Resistant Progressive Histiocytosis X

HISTIOCYTOSIS X is the name for a spectrum of rare disorders — Letterer–Siwe disease, Hand–Schüller–Christian disease, and eosinophilic granuloma 1 2 3 — that have a wide range of clinical manifestations but are all characterized by granuloma formation, with infiltration and proliferation of histioc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1987-03, Vol.316 (12), p.733-735
Hauptverfasser: Ringdén, Olle, Åhström, Lars, Lönnqvist, Berit, Båryd, Ingvar, Svedmyr, Erik, Gahrton, Gösta
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 735
container_issue 12
container_start_page 733
container_title The New England journal of medicine
container_volume 316
creator Ringdén, Olle
Åhström, Lars
Lönnqvist, Berit
Båryd, Ingvar
Svedmyr, Erik
Gahrton, Gösta
description HISTIOCYTOSIS X is the name for a spectrum of rare disorders — Letterer–Siwe disease, Hand–Schüller–Christian disease, and eosinophilic granuloma 1 2 3 — that have a wide range of clinical manifestations but are all characterized by granuloma formation, with infiltration and proliferation of histiocytes. In many cases, the symptoms include pain caused by one or more bone lesions. Lymph-node involvement occurs frequently in younger patients. The benign forms of histiocytosis X are characterized by spontaneous remissions and exacerbations. Disseminated fulminant disease progresses rapidly and has an unfavorable outcome. The diagnosis is based on histologie criteria, which can be used as guidelines for prognosis . . .
doi_str_mv 10.1056/NEJM198703193161207
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77415790</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4321446647</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-d653c0a29bb2df5e416bd44bcf60d68e4da1f4fc143b12bc1df1e3b5688e1f173</originalsourceid><addsrcrecordid>eNp9kVFrFDEQx4Mo9Vr9BCIEFF9kNZNkN9nHelSrtFqkgm9LNjvby7mbnEmu5b69KXf0QcR5yZD_b_6TzBDyAtg7YHXz_uvZl0totWICWgENcKYekQXUQlRSsuYxWTDGdSVVK56S45TWrATI9ogciVoq4HpBfp1OU7hBj87SD8EjvTQxhjt6HY1Pm8n4bLILnjpPDb0qOfpM71xe0eUK55BXGM1mV33H5FIuNL2K4SZiSu4W6Xm5c8Hucigq_fmMPBnNlPD54TwhPz6eXS_Pq4tvnz4vTy8qK1qRq6GphWWGt33Ph7FGCU0_SNnbsWFDo1EOBkY5WpCiB95bGEZA0deN1ggjKHFC3ux9NzH83mLK3eySxan8BsM2dUpJqFXLCvjqL3AdttGXt3WgtYRWcikKJfaUjSGliGO3iW42cdcB6-4X0f1jEaXq5cF72884PNQcJl_01wfdJGumsczbuvSAaa64YPfY2z02z6nzuJ7_2_QPs6Cdsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1884194243</pqid></control><display><type>article</type><title>Allogeneic Bone Marrow Transplantation in a Patient with Chemotherapy-Resistant Progressive Histiocytosis X</title><source>MEDLINE</source><source>ProQuest Central UK/Ireland</source><creator>Ringdén, Olle ; Åhström, Lars ; Lönnqvist, Berit ; Båryd, Ingvar ; Svedmyr, Erik ; Gahrton, Gösta</creator><creatorcontrib>Ringdén, Olle ; Åhström, Lars ; Lönnqvist, Berit ; Båryd, Ingvar ; Svedmyr, Erik ; Gahrton, Gösta</creatorcontrib><description>HISTIOCYTOSIS X is the name for a spectrum of rare disorders — Letterer–Siwe disease, Hand–Schüller–Christian disease, and eosinophilic granuloma 1 2 3 — that have a wide range of clinical manifestations but are all characterized by granuloma formation, with infiltration and proliferation of histiocytes. In many cases, the symptoms include pain caused by one or more bone lesions. Lymph-node involvement occurs frequently in younger patients. The benign forms of histiocytosis X are characterized by spontaneous remissions and exacerbations. Disseminated fulminant disease progresses rapidly and has an unfavorable outcome. The diagnosis is based on histologie criteria, which can be used as guidelines for prognosis . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM198703193161207</identifier><identifier>PMID: 3547128</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>Boston, MA: Massachusetts Medical Society</publisher><subject>Adult ; Biological and medical sciences ; Bone Marrow Transplantation ; DNA - biosynthesis ; Drug Resistance ; Eosinophilic Granuloma - therapy ; Graft vs Host Disease - prevention &amp; control ; Hematologic and hematopoietic diseases ; Histiocytosis, Langerhans-Cell - therapy ; Humans ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymphocytes - metabolism ; Male ; Medical sciences ; Transplantation, Homologous</subject><ispartof>The New England journal of medicine, 1987-03, Vol.316 (12), p.733-735</ispartof><rights>1987 INIST-CNRS</rights><rights>Copyright Massachusetts Medical Society Mar 19, 1987</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-d653c0a29bb2df5e416bd44bcf60d68e4da1f4fc143b12bc1df1e3b5688e1f173</citedby><cites>FETCH-LOGICAL-c393t-d653c0a29bb2df5e416bd44bcf60d68e4da1f4fc143b12bc1df1e3b5688e1f173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1884194243?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8272308$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3547128$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ringdén, Olle</creatorcontrib><creatorcontrib>Åhström, Lars</creatorcontrib><creatorcontrib>Lönnqvist, Berit</creatorcontrib><creatorcontrib>Båryd, Ingvar</creatorcontrib><creatorcontrib>Svedmyr, Erik</creatorcontrib><creatorcontrib>Gahrton, Gösta</creatorcontrib><title>Allogeneic Bone Marrow Transplantation in a Patient with Chemotherapy-Resistant Progressive Histiocytosis X</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>HISTIOCYTOSIS X is the name for a spectrum of rare disorders — Letterer–Siwe disease, Hand–Schüller–Christian disease, and eosinophilic granuloma 1 2 3 — that have a wide range of clinical manifestations but are all characterized by granuloma formation, with infiltration and proliferation of histiocytes. In many cases, the symptoms include pain caused by one or more bone lesions. Lymph-node involvement occurs frequently in younger patients. The benign forms of histiocytosis X are characterized by spontaneous remissions and exacerbations. Disseminated fulminant disease progresses rapidly and has an unfavorable outcome. The diagnosis is based on histologie criteria, which can be used as guidelines for prognosis . . .</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Bone Marrow Transplantation</subject><subject>DNA - biosynthesis</subject><subject>Drug Resistance</subject><subject>Eosinophilic Granuloma - therapy</subject><subject>Graft vs Host Disease - prevention &amp; control</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Histiocytosis, Langerhans-Cell - therapy</subject><subject>Humans</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymphocytes - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Transplantation, Homologous</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kVFrFDEQx4Mo9Vr9BCIEFF9kNZNkN9nHelSrtFqkgm9LNjvby7mbnEmu5b69KXf0QcR5yZD_b_6TzBDyAtg7YHXz_uvZl0totWICWgENcKYekQXUQlRSsuYxWTDGdSVVK56S45TWrATI9ogciVoq4HpBfp1OU7hBj87SD8EjvTQxhjt6HY1Pm8n4bLILnjpPDb0qOfpM71xe0eUK55BXGM1mV33H5FIuNL2K4SZiSu4W6Xm5c8Hucigq_fmMPBnNlPD54TwhPz6eXS_Pq4tvnz4vTy8qK1qRq6GphWWGt33Ph7FGCU0_SNnbsWFDo1EOBkY5WpCiB95bGEZA0deN1ggjKHFC3ux9NzH83mLK3eySxan8BsM2dUpJqFXLCvjqL3AdttGXt3WgtYRWcikKJfaUjSGliGO3iW42cdcB6-4X0f1jEaXq5cF72884PNQcJl_01wfdJGumsczbuvSAaa64YPfY2z02z6nzuJ7_2_QPs6Cdsg</recordid><startdate>19870319</startdate><enddate>19870319</enddate><creator>Ringdén, Olle</creator><creator>Åhström, Lars</creator><creator>Lönnqvist, Berit</creator><creator>Båryd, Ingvar</creator><creator>Svedmyr, Erik</creator><creator>Gahrton, Gösta</creator><general>Massachusetts Medical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>19870319</creationdate><title>Allogeneic Bone Marrow Transplantation in a Patient with Chemotherapy-Resistant Progressive Histiocytosis X</title><author>Ringdén, Olle ; Åhström, Lars ; Lönnqvist, Berit ; Båryd, Ingvar ; Svedmyr, Erik ; Gahrton, Gösta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-d653c0a29bb2df5e416bd44bcf60d68e4da1f4fc143b12bc1df1e3b5688e1f173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Bone Marrow Transplantation</topic><topic>DNA - biosynthesis</topic><topic>Drug Resistance</topic><topic>Eosinophilic Granuloma - therapy</topic><topic>Graft vs Host Disease - prevention &amp; control</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Histiocytosis, Langerhans-Cell - therapy</topic><topic>Humans</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymphocytes - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Transplantation, Homologous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ringdén, Olle</creatorcontrib><creatorcontrib>Åhström, Lars</creatorcontrib><creatorcontrib>Lönnqvist, Berit</creatorcontrib><creatorcontrib>Båryd, Ingvar</creatorcontrib><creatorcontrib>Svedmyr, Erik</creatorcontrib><creatorcontrib>Gahrton, Gösta</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ringdén, Olle</au><au>Åhström, Lars</au><au>Lönnqvist, Berit</au><au>Båryd, Ingvar</au><au>Svedmyr, Erik</au><au>Gahrton, Gösta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Allogeneic Bone Marrow Transplantation in a Patient with Chemotherapy-Resistant Progressive Histiocytosis X</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1987-03-19</date><risdate>1987</risdate><volume>316</volume><issue>12</issue><spage>733</spage><epage>735</epage><pages>733-735</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>HISTIOCYTOSIS X is the name for a spectrum of rare disorders — Letterer–Siwe disease, Hand–Schüller–Christian disease, and eosinophilic granuloma 1 2 3 — that have a wide range of clinical manifestations but are all characterized by granuloma formation, with infiltration and proliferation of histiocytes. In many cases, the symptoms include pain caused by one or more bone lesions. Lymph-node involvement occurs frequently in younger patients. The benign forms of histiocytosis X are characterized by spontaneous remissions and exacerbations. Disseminated fulminant disease progresses rapidly and has an unfavorable outcome. The diagnosis is based on histologie criteria, which can be used as guidelines for prognosis . . .</abstract><cop>Boston, MA</cop><pub>Massachusetts Medical Society</pub><pmid>3547128</pmid><doi>10.1056/NEJM198703193161207</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 1987-03, Vol.316 (12), p.733-735
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_77415790
source MEDLINE; ProQuest Central UK/Ireland
subjects Adult
Biological and medical sciences
Bone Marrow Transplantation
DNA - biosynthesis
Drug Resistance
Eosinophilic Granuloma - therapy
Graft vs Host Disease - prevention & control
Hematologic and hematopoietic diseases
Histiocytosis, Langerhans-Cell - therapy
Humans
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphocytes - metabolism
Male
Medical sciences
Transplantation, Homologous
title Allogeneic Bone Marrow Transplantation in a Patient with Chemotherapy-Resistant Progressive Histiocytosis X
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T19%3A10%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Allogeneic%20Bone%20Marrow%20Transplantation%20in%20a%20Patient%20with%20Chemotherapy-Resistant%20Progressive%20Histiocytosis%20X&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Ringd%C3%A9n,%20Olle&rft.date=1987-03-19&rft.volume=316&rft.issue=12&rft.spage=733&rft.epage=735&rft.pages=733-735&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJM198703193161207&rft_dat=%3Cproquest_cross%3E4321446647%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1884194243&rft_id=info:pmid/3547128&rfr_iscdi=true